Open Demat Account

50years
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O
left-arrow
Fundamentals
Financials
Shareholding
Resistance/Support
Delivery and Volume
About
Management
News
Similar Stocks
right-arrow

Global Health Ltd Performance

Today's Low
1,332.35
arrowIcon
Today's High
1,409.00
52 Wk Low
485.05
arrowIcon
52 Wk High
1,513.90


Open

1332.35

Traded Value (Cr)

21.69 Cr

Prev. Close

1372.95

VWAP

1391.47

Volume

1,18,361

Face Value

2

Global Health Ltd Fundamentals

Market Cap
₹ 37,397 Cr
P/E Ratio (TTM)
82.76
P/B Ratio
14.09
Debt to Equity
0.30
ROE
15.40 %
EPS (TTM)
16.83
Dividend Yield
0.00%
Book Value
98.85

Click here to know more about Fundamentals

Global Health Ltd Financials

Global Health Ltd Financials

Global Health Ltd Shareholding Pattern

Held By Mar 2024 Dec 2023 Sep 2023 Jun 2023
Others 39.45 % 40.16 % 41.17 % 41.56 %
Promoters 33.04 % 33.05 % 33.06 % 33.07 %
FII 12.09 % 11.36 % 10.69 % 10.58 %
Mutual Funds 8.27 % 8.63 % 8.24 % 7.99 %
Retail 7.14 % 6.79 % 6.85 % 6.79 %

Others

39.45%

Promoters

33.04%

FII

12.09%

Mutual Funds

8.27%

Retail

7.14%

Others

40.16%

Promoters

33.05%

FII

11.36%

Mutual Funds

8.63%

Retail

6.79%

Others

41.17%

Promoters

33.06%

FII

10.69%

Mutual Funds

8.24%

Retail

6.85%

Others

41.56%

Promoters

33.07%

FII

10.58%

Mutual Funds

7.99%

Retail

6.79%

Resistance and Support

₹1,383.85

PIVOT

resistance-arrow
Resistance
First Resistance₹1,398.650
Second Resistance₹1,410.800
Third Resistance₹1,425.600
support-arrow
Support
First Resistance₹1,371.700
Second Resistance₹1,356.900
Third Resistance₹1,344.750
RSI64.479
MACD84.114
ADX15.587
CCI62.896

Delivery and Volume

PeriodDelivery Volume Traded Volume Delivery Volume %
Day118,36188,50057.29
Week203,091104,62872.30
1 Month341,952258,52170.70
6 Months118,36173,13261.79

About Global Health Ltd

Global Health Limited was incorporated as Global Health Private Limited' on August 13, 2004 at New Delhi, India as a Private Limited Company under the Companies Act, 1956. The Company converted into a Public Limited Company, passed by Shareholders at the EGM held on July 31, 2021 and consequently, name of the Company was changed to Global Health Limited' dated August 11, 2021 issued by the RoC. The Company was founded by Dr. Naresh Trehan, a world-renowned cardiovascular and cardiothoracic surgeon. The Company is one of the largest private multi-speciality tertiary care providers operating in the North and East regions of India in terms of bed capacity with key specialties of cardiology and cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopaedics, liver transplant, and kidney and urologoly. Under the 'Medanta' brand, it has a network of 5 hospitals currently in operation including, Gurugram, Indore, Ranchi, Lucknow and Patna and one hospital in Noida, which is under construction. As at June 30, 2022, the Company provide healthcare services in over 30 medical specialties and is engaged over 1,300 doctors led by experienced department heads and, spanning an area of 4.7 million sq. ft., their operational hospitals have 2,467 installed beds to serve Indian and international patients. In November 2009, the Company opened its flagship hospital in Gurugram. In 2015, its subsidiary, Global Health Patliputra Private Limite (GHPPL), entered into a Concession Agreement with Governor of Bihar for the development, operation and maintenance of a proposed hospital on public-private partnership at Patna. In 2019, it commenced operations of new hospital at Lucknow. In 2020, Patna hospital's outpatient department facility was launched and the inpatient department facility of its Patna hospital was inaugurated in October 2021, which commenced operations during year 2022. The Company has taken in-house facility and operate pharmacies at its Gurugram, Lucknow, Indore and Ranchi hospitals as well as launched an outpatient department pharmacy at South Delhi clinic in year 2021 and launched outpatient department pharmacy at South Delhi clinic at Patna hospital in year 2022. As at June 30, 2022, it had 200 installed beds and employed over 50 doctors across key specialties such as neuroscience and cardiac sciences. Patna hospital had 228 installed beds and employed over 125 doctors as at June 30, 2022 and is designed to accommodate over 500 beds. In the Board Meeting dated 25 January 2021, the Board of Directors of the Holding Company have approved capital raising comprising of fresh issue and offer for sale of equity shares by the existing shareholders through an Initial Public Offering (IPO) The Company came out with a public issue during November, 2022 by raising Rs. 2205.57 crores through fresh issue amounting to Rs. 500 crores and offer for sale amounting to Rs. 1705.57 crores. The Company's Lucknow hospital added 191 beds in FY23, including over 90 critical care beds. Lucknow hospital also added seven new OTs and have hired over 50 senior clinicians. Towards the end of FY23, Lucknow hospital commissioned the Siemens Varian EDGE Radiation Oncology machine - the first in North India - as well as set up a dedicated e-ICU Command Centre to assist in remote critical care management. The Company's Patna hospital added over 100 beds and 35+ doctors in FY23. In FY23, the Company also announced a new 300- bed hospital project in Indore under the asset-light O&M model. It started Medanta Labs in January 2023. During the year 2022-23, GHL Pharma was incorporated as a wholly-owned subsidiary on June 29, 2022.

Managing Director

Naresh Kumar Trehan

Founded

2004

NSE Symbol

MEDANTA

Global Health Ltd Management

NameDesignation
Naresh Kumar TrehanChairman & Managing Director
Pankaj Prakash SahniGroup CEO & WTD
Hari S BhartiaIndependent Non Exe. Director
Praveen MahajanIndependent Non Exe. Director
Rajan Bharti MittalIndependent Non Exe. Director
RAVI GUPTAIndependent Non Exe. Director
RAVI KANT JAIPURIANon Executive Director / Nomin
SUNIL SACHDEVANon Executive Director
Venkatesh RatnasamiNon Executive Director / Nomin
Vikram Singh MehtaIndependent Non Exe. Director

Global Health Ltd News

Global Health allots 20,000 equity shares under ESOP
Global Health corrects on profit selling
Global Health dropped 3.23% to Rs 1388 on profit selling after a recent steep rise.
Global Health announces change in senior management
Global Health allots 20,000 equity shares under ESOP
Board of Global Health appoints CFO
At meeting held on 08 February 2024
Global Health consolidated net profit rises 53.38% in the December 2023 quarter
Sales rise 19.92% to Rs 832.60 crore
Global Health to announce Quarterly Result
On 8 February 2024
Global Health CFO Sanjeev Kumar resigns
Global Health announced that Sanjeev Kumar has resigned from the position of chief financial officer (CFO) of the company due to personal reason.
Global Health announces resignation of CFO
Global Health consolidated net profit rises 46.08% in the September 2023 quarter
Sales rise 24.28% to Rs 843.94 crore

Similar Stocks

CompanyMarket CapMarket PriceP/E Ratio
APOLLOHOSP₹ 88,708 Cr
₹ 6,169.55
(1.57 %)
88.84
MAXHEALTH₹ 75,114 Cr
₹ 772.85
(-0.67 %)
131.28
FORTIS₹ 32,478 Cr
₹ 430.20
(-1.34 %)
426.39
ASTERDM₹ 26,004 Cr
₹ 520.60
(-0.23 %)
120.00
NH₹ 25,390 Cr
₹ 1,242.45
(0.32 %)
70.79

Global Health Ltd FAQ

By opening a demat account and having your KYC papers confirmed online, you may simply purchase Global Health Ltd shares in BlinkX

The share price of any stock is volatile and changes during the day due to a variety of variables. Global Health Ltd's share price is ₹1,403.70 as of April 19, 2024

Global Health Ltd's P/E ratio is 82.76 times as of April 19, 2024.

Global Health Ltd's most recent financial reports indicate a price-to-book ratio of 14.09, showing the company's stock market valuation in relation to the value of its real assets.

Market capitalisation, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Global Health Ltd's market is 37,398 Cr as on April 19, 2024.

The current financial records of Global Health Ltd show a 15.40% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.

The 52-week high/low price of a Global Health Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Global Health Ltd's 52-week high and low as of April 19, 2024 are ₹1409 and ₹1332.35 respectively.

As of the Mar 2024 quarter, the promoter shareholding in Global Health Ltd stands at 33.04%. During the same period, Institutional Investors have shown a slight increase in their holdings, rising from 11.36% to 12.09%.